Investor Relations

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Recent Releases

Mar 8, 2010
Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2009 Financial Results on March 15, 2010

Mar 2, 2010
Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Cowen and Company 30th Annual Health Care Conference in Boston on March 9, 2010

Events

Mar 15, 2010
Cadence Pharmaceuticals 4th Quarter 2010 Earnings Release

Mar 9, 2010
Cowen and Company 30th Annual Health Care Conference

more »